Assessing the Probability That a Positive Report is False: An Approach for Molecular Epidemiology StudiesSholom Wacholder, Nathaniel Rothman, Stephen J. Chanock et al.|JNCI Journal of the National Cancer Institute|2004Cited by 1.8k
NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analysesMontserrat García‐Closas, Nathaniel Rothman, Stephen J. Chanock et al.|The Lancet|2005Cited by 631
Hematotoxicity in Workers Exposed to Low Levels of BenzeneQing Lan, Martyn T. Smith, Luoping Zhang et al.|Science|2004Cited by 623
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph ConsortiumNathaniel Rothman, Alexandra Nieters, Christine F. Skibola et al.|The Lancet Oncology|2005Cited by 378
Reporting, Appraising, and Integrating Data on Genotype Prevalence and Gene-Disease AssociationsJulian Little, Clarice R. Weinberg, Linda Bradley et al.|American Journal of Epidemiology|2002Cited by 372